{"transactions":[{"id":3855114,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":169314,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855113,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The warrant to purchase 17,600 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 35,200 shares."}],"balance_after":17600,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":35200},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855112,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":153114,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."}],"balance_after":170714,"derivative":{"exercise_price":6.25,"underlying":"Common Stock","underlying_shares":153114},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855111,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"A warrant to purchase 17,600 shares of common stock was issued upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."}],"balance_after":17600,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855110,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":153114,"price":0.44,"value":67370.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":153114},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855109,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":40382,"ownership":{"direct":false,"nature":"Medico-Trans Company, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 40,382 shares were received upon consummation of the initial public offering in accordance with a Services Agreement with Medico-Trans Company, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The 40,382 shares were received upon consummation of the initial public offering in accordance with a Services Agreement with Medico-Trans Company, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Medico-Trans Company, LLC is controlled by Bankole Johnson."}],"balance_after":313750,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855108,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855107,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The 17,600 shares were received upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 17,600 shares were received upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."}],"balance_after":273368,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855106,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":153114,"price":0.44,"value":67370.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."}],"balance_after":255768,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}}]}